Meeting on the Mesa 2025 Arrives Amid Mixed Signals for Cell and Gene Therapy Sector

The Cell & Gene Meeting on the Mesa 2025 is taking place October 6–8, 2025, at the Arizona Biltmore in Phoenix1 3 5 7.

This conference is the leading annual event for the cell and gene therapy sector, gathering over 2,000 senior leaders including executives, scientists, investors, and strategic decision-makers2 3 4 5.

The event features panels, workshops, more than 100 company presentations, and over 5,000 partnering meetings, offering a major platform for networking, dialogue, and collaboration within the industry2 3 4.

Key agenda topics include the latest scientific advances, commercialization pathways, clinical trial design, alternative payment models, scale-up and supply chain platforms, and regulatory solutions for advanced therapies2 3 5 7.

The meeting will highlight significant clinical and commercial progress but also address persistent challenges such as high costs, slow timelines, regulatory hurdles, and uncertainties in reimbursement for new cell and gene therapies5 7.

There is sector-wide anticipation for partnerships and innovative strategies to accelerate development, while simultaneously grappling with persistent obstacles in widespread adoption and sustainable business models, creating mixed market signals about the industry's future prospects5 7.

Major companies and organizations—including CDMO/CRO service providers and manufacturing experts—are using the event to showcase solutions aimed at expediting drug development and improving access to next-generation therapies1 5 6.